Feasibility and safety of 1.5  T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes.

CONCLUSION: This is the first report documenting for older cancer patients that 1.5 T MRI-guided daily-adapted SBRT is feasible, safe and does not impact on the QoL at the end of treatment. Longer follow-up is advocated to report long-term outcomes.
TRIAL REGISTRATION: Date of approval April 2019 and numbered MRI/LINAC no. 23748.
PMID: 32372146 [PubMed - indexed for MEDLINE]

Source: Clinical Prostate Cancer - August 13, 2020 Category: Cancer & Oncology Authors: Mazzola R, Figlia V, Rigo M, Cuccia F, Ricchetti F, Giaj-Levra N, Nicosia L, Vitale C, Sicignano G, De Simone A, Naccarato S, Ruggieri R, Alongi F Tags: J Cancer Res Clin Oncol Source Type: research